Finance

Lists
002349:SHE
Jinghua Pharmaceutical Group Co Ltd
CN¥8.05
+1.90%
(+0.15) 1D
Oct 16, 3:04:09 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002349...
Open
CN¥7.89
High
CN¥8.45
Low
CN¥7.86
Mkt. cap
7.20B
Avg. vol.
79.01M
Volume
65.78M
Dividend
1.12%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 29, 2026
P/E ratio
29.38
52-wk high
CN¥9.59
52-wk low
CN¥5.99
EPS
CN¥0.27
Shares outstanding
831.07M
No. of employees
1K
Open
CN¥7.89
High
CN¥8.45
Low
CN¥7.86
Mkt. cap
7.20B
Avg. vol.
79.01M
Volume
65.78M
Dividend
1.12%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 29, 2026
P/E ratio
29.38
52-wk high
CN¥9.59
52-wk low
CN¥5.99
EPS
CN¥0.27
Shares outstanding
831.07M
No. of employees
1K
News stories
From web sources and news partners
About Jinghua Pharmaceutical Group Co Ltd
CEO-
Employees1.46K
Founded1957
Headquarters-
SectorPharmaceutical industry
Websitentjhzy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
360.86M
367.67M
379.76M
375.01M
Cost of goods sold
173.69M
196.06M
169.42M
180.05M
Cost of revenue
173.69M
196.06M
169.42M
180.05M
Research and development expenses
14.70M
21.45M
14.29M
15.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
105.07M
99.33M
96.62M
83.95M
Operating expense
124.89M
125.31M
117.85M
105.08M
Total operating expenses
298.58M
321.37M
287.26M
285.13M
Operating income
62.29M
46.30M
92.50M
89.88M
Other non operating income
-1.59M
1.52M
-1.88M
1.75M
EBT including unusual items
67.91M
60.56M
94.49M
98.29M
EBT excluding unusual items
70.73M
51.60M
96.39M
92.68M
Income tax expense
10.05M
8.28M
12.74M
14.80M
Effective tax rate
14.79%
13.66%
13.49%
15.05%
Other operating expenses
5.43M
4.59M
5.10M
5.40M
Net income
45.73M
42.91M
65.87M
70.25M
Net profit margin
12.67%
11.67%
17.35%
18.73%
Earnings per share
-
-
-
-
Interest and investment income
9.58M
6.44M
5.88M
5.53M
Interest expense
-
-115.63K
-116.59K
-399.11K
Net interest expenses
9.58M
6.33M
5.77M
5.13M
Depreciation and amortization charges
-
-
-
-
EBITDA
81.02M
66.16M
112.36M
108.77M
Gain or loss from assets sale
28.38K
5.09K
-
-7.11K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps